Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/61823
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKononov, S.-
dc.contributor.authorAzarova, L.-
dc.contributor.authorKlyosova, E.-
dc.contributor.authorBykanova, M.-
dc.contributor.authorChurnosov, M.-
dc.date.accessioned2024-03-29T12:30:57Z-
dc.date.available2024-03-29T12:30:57Z-
dc.date.issued2023-
dc.identifier.citationLipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease / S. Kononov, L. Azarova, E. Klyosova [et al.] // Genes. - 2023. - Vol.14, №6.-Art. 1259.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/61823-
dc.description.abstractWe have shown that lipid-associated loci discovered by genome-wide association studies (GWAS) have pleiotropic effects on lipid metabolism, carotid intima-media thickness (CIMT), and CAD risk. Here, we investigated the impact of lipid-associated GWAS loci on the efficacy of rosuvastatin therapy in terms of changes in plasma lipid levels and CIMTru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectmedical geneticsru
dc.subjectcoronary artery diseaseru
dc.subjectplasma lipidsru
dc.subjectcarotid intima-media thicknessru
dc.subjectpharmacogeneticsru
dc.subjectpersonalized medicineru
dc.subjectsingle nucleotide polymorphismsru
dc.subjectlipid-lowering therapyru
dc.subjectrosuvastatinru
dc.titleLipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Diseaseru
dc.typeArticleru
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Churnosov_Lipid_23.pdf507.38 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.